Updated on 30 November 2012
Ms Alison Mew (seen in the image) has been appointed as CEO and Dr Mal Brandon as chairman by Genetic Technologies
Singapore: The board of Genetic Technologies announced the appointment of Dr Mal Brandon to the position of chairman of the board. The board also announced that Ms Alison Mew, the company's current chief operating officer, has been appointed to the position of acting chief executive officer, following the resignation of Dr Paul MacLeman.
Dr Brandon, while speaking about the appointment, said that, "The board is confident that the company will continue to build on the solid foundation that has been created and looks forward to further expansion of its US operations and its global licensing programs."